Pharmaceutical

Kiniksa Pharmaceuticals sees highest patent filings and grants during April in Q2 2024

Kiniksa Pharmaceuticals sees highest patent filings and...

Jul 22, 2024

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Y-mAbs Therapeutics sees highest patent filings and grants during June in Q2 2024

Y-mAbs Therapeutics sees highest patent filings and gra...

Jul 22, 2024

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Medicover sees highest patent filings and grants during May in Q2 2024

Medicover sees highest patent filings and grants during...

Jul 22, 2024

Access and buy GlobalData’s databook on the latest filings and grants activity f...

iTeos Therapeutics sees highest patent filings and grants during May in Q2 2024

iTeos Therapeutics sees highest patent filings and gran...

Jul 22, 2024

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval

Rusan Pharma’s API Plant in Ankleshwar Receives USFDA G...

Jul 22, 2024

Rusan Pharma's new facility in India will enhance its global capabilities and ex...

Certara sees highest patent filings and grants during June in Q2 2024

Certara sees highest patent filings and grants during J...

Jul 22, 2024

Access and buy GlobalData’s databook on the latest filings and grants activity f...

FDA launches new rare disease innovation hub

FDA launches new rare disease innovation hub

Jul 20, 2024

The new hub will act as a central point of connection and engagement for the rar...

BMS gains EMA validation for Opdivo/Yervoy combo in liver cancer

BMS gains EMA validation for Opdivo/Yervoy combo in liv...

Jul 20, 2024

The Opdivo/Yervoy combination demonstrated statistically and clinically signific...

Tech leader’s $125m boosts Parker Institutes immunotherapy research

Tech leader’s $125m boosts Parker Institutes immunother...

Jul 20, 2024

The Parker Institute for Cancer Immunotherapy was founded in 2016 by tech entrep...

Boehringer Ingelheim offers Humira biosimilar at 92% discount

Boehringer Ingelheim offers Humira biosimilar at 92% di...

Jul 20, 2024

Boehringer Ingelheim will sell an unbranded copycat of Humira through GoodRx for...

Exscientia acquires oral CDK7 inhibitor for $20m, plans breast cancer trial

Exscientia acquires oral CDK7 inhibitor for $20m, plans...

Jul 20, 2024

Exscientia paid $20m in upfront cash and equity to buy its development partner G...

Seventh patient ‘cured’ of HIV among highlights at AIDS 2024

Seventh patient ‘cured’ of HIV among highlights at AIDS...

Jul 20, 2024

New global projections and advances in HIV therapies are also on the agenda at t...

Rona Therapeutics gains Series A+ funds for siRNA pipeline expansion

Rona Therapeutics gains Series A+ funds for siRNA pipel...

Jul 20, 2024

Rona Therapeutics has secured $35m in its Series A+ financing round to advance i...

Meitheal gains rights to CONTEPO from Nabriva in North America

Meitheal gains rights to CONTEPO from Nabriva in North ...

Jul 20, 2024

Meitheal Pharmaceuticals has gained rights to CONTEPO (fosfomycin for injection)...

EMA accepts Deciphera’s MAA cell tumour treatment for review

EMA accepts Deciphera’s MAA cell tumour treatment for r...

Jul 20, 2024

The EMA has accepted the MAA of Deciphera Pharmaceuticals' vimseltinib to treat ...

Ardelyx sues CMS over revamped kidney disease drug payment bundle

Ardelyx sues CMS over revamped kidney disease drug paym...

Jul 20, 2024

Ardelyx and two other organisations have filed a lawsuit, opposing the HHS' and ...

44
45
46
47
48